Try our Advanced Search for more refined results

May 04, 2021

Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 01, 2022

    Novartis Patent Suit Over Generic MS Drug Won't Be Trimmed

    A Delaware federal judge rebuffed a generic-drug maker's call to let its subsidiaries out of Novartis' patent suit over multiple sclerosis drug Gilenya, ruling Tuesday that the generic company's units each played a role in the alleged infringement.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login